COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 2119: Articles 21181-21190  | Next

Asymptomatic Employee Screening for SARS-CoV-2: Implementation of and Reactions to an Employer-Based Testing Program.
Goetz, L., DeLaughder, T. L., Kennedy, K. L., Schork, N., McDaniel, T., Trent, J., Engelthaler, D.
10.1101/2020.11.06.20227314 — Posted: 2020-11-10
Challenges of Deep Learning Methods for COVID-19 Detection Using Public Datasets
Hasan, M. K., Alam, M. A., Dahal, L., Elahi, M. T. E., Roy, S., Wahid, S. R., Marti, R., Khanal, B.
10.1101/2020.11.07.20227504 — Posted: 2020-11-10
Symptoms suggestive of COVID-19 in households with and without children: a descriptive survey
Grove, G., Ziauddeen, N., Alwan, N. A.
10.1101/2020.11.09.20228205 — Posted: 2020-11-10
The COVID-19 epidemic in the Czech Republic: retrospective analysis of measures (not) implemented during the spring first wave
Berec, L., Smycka, J., Levinsky, R., Hromadkova, E., Soltes, M., Slerka, J., Tucek, V., Trnka, J., Smid, M., Zajicek, M., Diviak, T., Neruda, R., Vidnerova, P.
10.1101/2020.11.06.20227330 — Posted: 2020-11-10
Synthetic Reproduction and Augmentation of COVID-19 Case Reporting Data by Agent-Based Simulation
Popper, N., Zechmeister, M., Brunmeir, D., Rippinger, C., Weibrecht, N., Urach, C., Bicher, M., Schneckenreither, G., Rauber, A.
10.1101/2020.11.07.20227462 — Posted: 2020-11-10
Universal epidemic curve for COVID-19 and its usage for forecasting
Sharma, A., Sapkal, S., Verma, M. K.
10.1101/2020.11.07.20220392 — Posted: 2020-11-10
Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry
Kirkup, C., Pawlowski, C., Puranik, A., Conrad, I., O'Horo, J. C., Gomaa, D., Banner-Goodspeed, V. M., Mosier, J. M., Zabolotskikh, I. B., Daugherty, S. K., Bernstein, M. A., Zaren, H. A., Bansal, V., Pickering, B., Badley, A. D., Kashyap, R., Venkatakrishnan, A., Soundararajan, V.
10.1101/2020.11.06.20226035 — Posted: 2020-11-10
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Anderson, E. M., Goodwin, E. C., Verma, A., Arevalo, C. P., Bolton, M. J., Weirick, M. E., Gouma, S., McAllister, C. M., Christensen, S. R., Weaver, J., Hicks, P., Manzoni, T. B., Oniyide, O., Ramage, H., Mathew, D., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., D'Andrea, K., Kuthuru, O., Dougherty, J., Pattekar, A., Kim, J., Han, N., Apostolidis, S. A., Huang, A. C., Vella, L., The UPenn COVID Processing Unit, , Wherry, E. J., Meyer, N. J., Cherry, S., Bates, P., Rader, D. J., Hensley, S. E.
10.1101/2020.11.06.20227215 — Posted: 2020-11-10 Discussion: Offsite
Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers
Oostvogels, L., Kremsner, P., Kreidenweiss, A., Leroux-Roels, I., Leroux-Roels, G., Kroidl, A., Schunk, M., Schindler, C., Bosch, J., Fendel, R., Gabor, J. J., Velavan, T. P., Mann, P., Walz, L., Mueller, S., Schoenborn-Kellenberger, O., Verstraeten, T., Fotin-Mleczek, M., Vahrenhorst, D., Quintini, G., Wolz, O.-O.
10.1101/2020.11.09.20228551 — Posted: 2020-11-09
Cloning, Expression and Biophysical Characterization of a Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain COVID-19 Vaccine Candidate
Chen, W.-H., Wei, J., Kundu, R. T., Adhikari, R., Liu, Z., Lee, J., Versteeg, L., Poveda, C., Keegan, B., Villar, M. J., de Araujo Leao, A. C., Altieri Rivera, J., Gillespie, P. M., Pollet, J., Strych, U., Zhan, B., Hotez, P. J., Bottazzi, M. E.
10.1101/2020.11.09.373449 — Posted: 2020-11-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).